Main Article Content

Abstract

Highlights:
1. This research contributes novel data to current studies by combining the potential of Centella asiatica extract with PEG-400 to develop a therapeutic agent aimed at improving cognitive function through an effective drug delivery system capable of penetrating the blood-brain barrier.
2. The findings of this study revealed that the combination of Centella asiatica extract and PEG-400 at an adequate ratio exhibits great potential as an acetylcholinesterase inhibitor.


Abstract
Cognitive impairment, caused by neurocognitive changes and neuroinflammation, affects 65.6 million elderly people worldwide and can interfere with their quality of life. Centella asiatica is recognized for its neuroprotective potential due to its active compounds. This study aimed to investigate the acetylcholinesterase inhibitory properties of Centella asiatica as potential therapeutic agents for cognitive decline. Polyethylene glycol 400 (PEG-400) was used to achieve an effective drug delivery system of Centella asiatica extract, facilitating the inhibition of the apoptosis signaling pathway and allowing neuroprotective agents to cross the blood-brain barrier (BBB). This research involved several testing stages, including gas chromatography-mass spectrometry (GC-MS) to identify active compounds (e.g., tryptamine, γ-sitosterol, and β-sitosterol) that contribute to cognitive function improvement. Particle size analysis (PSA) tests were conducted on three formulations of the extract and PEG-400, with ratios of 1:100, 100:1, and 1:1, to determine the optimal formulation for subsequent testing. Scanning electron microscopy (SEM) was utilized to observe the morphology and surface structure of the samples, while Ellman's method was employed to test the ability of acetylcholine (ACh) in improving cognitive abilities. The results subsequently underwent descriptive analysis, particle distribution analysis, analysis of variance (ANOVA), nonparametric tests, image analysis, regression tests, multivariate analysis, and correlation tests. The synthesis demonstrated that the 1:100 formulation produced ideal-sized nanoparticles (5–7 nm), optimal for penetrating the BBB. The PSA and SEM analyses supported this finding by demonstrating homogeneous particle morphology and consistent chemical composition. The in vitro Ellman's assay revealed a high inhibitory rate of 97.63% for the 100:1 formulation. The 1:1 and 1:100 formulations demonstrated a very high effectiveness as acetylcholinesterase inhibitors. The combination of PEG-400 and Centella asiatica extract has great potential as an innovative pharmacological therapy for cognitive decline. However, further research is required to ensure the right dosage and development of the research findings.

Keywords

Cognitive Function Gotu kola (Centella asiatica (L.) Urban) Nanoparticles Geriatric Herbal medicine

Article Details

How to Cite
Nathania Nathania, Selvina Cindy Kusumaningrum, Reny I’tishom, Feranita Kumalasari, & Ria Margiana. (2024). Centella asiatica Nanoparticles as Potential Acetylcholinesterase Inhibitor for Cognitive Decline Therapy using Ellman’s Method: An in Vitro Study. Folia Medica Indonesiana, 60(4), 271–280. https://doi.org/10.20473/fmi.v60i4.62182

References

  1. Ambavade, S.D., Misar, A.V. and Ambavade, P.D. (2014). Pharmacological, nutritional, and analytical aspects of β-sitosterol: a review. Oriental Pharmacy and Experimental Medicine 14(3),. 193–211 (doi: 10.1007/s13596-014-0151-9)
  2. Chen, S. et al. (2014). Asiaticoside attenuates memory impairment induced by transient cerebral ischemia–reperfusion in mice through anti-inflammatory mechanism. Pharmacology Biochemistry and Behavior 122, 7–15 (doi: 10.1016/j.pbb.2014.03.004)
  3. Decker, A.L. and Duncan, K. (2020) 'Acetylcholine and the complex interdependence of memory and attention,' Current Opinion in Behavioral Sciences, 32,. 21-28. (doi.org/10.1016/j.cobeha.2020.01.013)
  4. Fan, J. et al. (2018). Asiatic acid ameliorates CC l4-induced liver fibrosis in rats: involvement of Nrf2/ARE, NF-κB/IκBα, and JAK1/STAT3 signaling pathways. Drug Design Development and Therapy, Volume 12, 3595–3605 (doi: 10.2147/dddt.s179876)
  5. Huang, X. et al. (2022). Comparative efficacy of various exercise interventions on cognitive function in patients with mild cognitive impairment or dementia: A systematic review and network meta-analysis. Journal of Sport and Health Science/Journal of Sport and Health Science 11(2), 212–223 (doi: 10.1016/j.jshs.2021.05.003)
  6. Jusril, N.A. et al. (2020) 'Combining In Silico and In Vitro Studies to Evaluate the Acetylcholinesterase Inhibitory Profile of Different Accessions and the Biomarker Triterpenes of Centella asiatica,' Molecules, 25(15), p. 3353. (doi.org/10.3390/molecules25153353.)
  7. Kostelnik, A., Cegan, A. and Pohanka, M. (2017). Acetylcholinesterase inhibitors assay using colorimetric pH sensitive strips and image analysis by a smartphone. International Journal of Analytical Chemistry 2017, 1–8 (doi: 10.1155/2017/3712384)
  8. Liu, Y.-Q. et al. (2022). Preparation and Safety Evaluation of Centella asiatica Total Glycosides Nitric Oxide Gel and Its Therapeutic Effect on Diabetic Cutaneous Ulcers. Evidence-based Complementary and Alternative Medicine 2022, 1–28 (doi: 10.1155/2022/1419146)
  9. Maryamabadi, A. et al. (2016). Application of PEG-400 as a green biodegradable polymeric medium for the catalyst-free synthesis of spiro-dihydropyridines and their use as acetyl and butyrylcholinesterase inhibitors. Bioorganic & Medicinal Chemistry 24(6), 1408–1417 (doi: 10.1016/j.bmc.2016.02.019)
  10. Moreta, M.P.-G. et al. (2021). Efficacy of acetylcholinesterase inhibitors on cognitive function in Alzheimer’s Disease. Review of reviews. Biomedicines 9(11), 1689 (doi: 10.3390/biomedicines9111689)
  11. Nguyen, N.-H. et al. (2020) 'Triterpenoids from the genus Gynostemma: Chemistry and pharmacological
  12. activities,' Journal of Ethnopharmacology, 268, p. 113574. https://doi.org/10.1016/j.jep.2020.113574.
  13. Olivia, N.U., Goodness, U.C. and Obinna, O.M. (2021). Phytochemical profiling and GC-MS analysis of aqueous methanol fraction of Hibiscus asper leaves. Future Journal of Pharmaceutical Sciences 7(1) (doi: 10.1186/s43094-021-00208-4)
  14. Patel, A.B. (2023). Simple and rapid colorimetric method for determination of erythrocyte and plasma cholinesterase activities and comparison with the standard Ellman’s method. Public Health Toxicology 3(3), 1–10 (doi: 10.18332/pht/172229)
  15. Puttarak, P. et al. (2017). Effects of Centella asiatica (L.) Urb. on cognitive function and mood related outcomes: A Systematic Review and Meta-analysis. Scientific Reports 7(1) (doi: 10.1038/s41598-017-09823-9)
  16. Sawicki, L.A. and Kloxin, A.M. (2016). Light-mediated formation and patterning of hydrogels for cell culture applications. Journal of Visualized Experiments [Preprint] (115) (doi: 10.3791/54462)
  17. Sharma, N., Tan, M.A. and An, S.S.A. (2021) 'Phytosterols: potential metabolic modulators in neurodegenerative
  18. diseases,' International Journal of Molecular Sciences, 22(22), p. 12255. https://doi.org/10.3390/ijms222212255.
  19. Shetab-Boushehri, S.V. (2018). Ellman’s method is still an appropriate method for measurement of cholinesterases activities. PubMed 17, 798–799 (doi: 10.17179/excli2018-1536)
  20. Slanzi, A. et al. (2020). In vitro Models of Neurodegenerative Diseases. Frontiers in Cell and Developmental Biology 8 (doi: 10.3389/fcell.2020.00328)
  21. Su, J. et al. (2017). Research Advances and Detection Methodologies for Microbe-Derived Acetylcholinesterase Inhibitors: A Systemic Review. Molecules 22(1), 176 (doi: 10.3390/molecules22010176)
  22. Špadina, M. et al. (2019). Synergistic solvent extraction is driven by entropy. ACS Nano 13(12), 13745–1375 (doi: 10.1021/acsnano.9b07605)
  23. Teleanu, D. et al. (2018). Blood -Brain delivery methods using nanotechnology. Pharmaceutis 10(4), 269 (doi: 10.3390/pharmaceutics10040269)
  24. Wei, X. et al. (2014). Compound identification in GC-MS by simultaneously evaluating the mass spectrum and retention index. The Analyst 139(10), 2507–2514 (doi: 10.1039/c3an02171h)
  25. World Health Organization: WHO. 2021. World failing to address dementia challenge. Available from: https://www.who.int/news/item/02-09-2021-world-failing-to-address-dementia-challenge2. Accessed July, 30 2024.
  26. Wright, K.M. et al. (2022). Developing a Rational, Optimized Product of Centella asiatica for Examination in Clinical Trials: Real World Challenges. Frontiers in Nutrition 8 (doi: 10.3389/fnut.2021.799137)
  27. Zinatloo-Ajabshir, S. (2022). Advanced rare earth-based ceramic nanomaterials at a glance, in Elsevier eBooks, pp. 1–11. (doi.org/10.1016/b978-0-323-89957-4.00011-6.)
  28. Zuin, M. et al. (2022). Acetyl-cholinesterase-inhibitors slow cognitive decline and decrease overall mortality in older patients with dementia. Scientific Reports 12(1) (doi: 10.1038/s41598-022-16476-w)

Most read articles by the same author(s)